Results 191 to 200 of about 17,763 (261)

Antifungal Agents in the 21st Century: Advances, Challenges, and Future Perspectives. [PDF]

Infect Dis Rep
Branda F, Petrosillo N, Ceccarelli G, Giovanetti M, De Vito A, Madeddu G, Scarpa F, Ciccozzi M.   +7 more
europepmc   +1 more source

The place of echinocandins in the treatment of recurrent vulvovaginal candidiasis: Case series

Mustafa Uğuz, Berfin Çirkin Doruk, İrem Yengel   +2 more
openalex   +1 more source

Review on the management of intra-abdominal candidiasis. [PDF]

Rev Esp Quimioter
Puerta-Alcalde P, Guinea J, Maseda E, Zaragoza R.   +3 more
europepmc   +1 more source

Rho2-dependent cell wall remodeling boosts the fungistatic activity of manogepix against <i>Aspergillus fumigatus</i>. [PDF]

Cell Surf
Brazil S, Kopp-Fouquet I, Yap SZK, Carty M, Wagener J.   +4 more
europepmc   +1 more source

Latest update in the management of pancreatic cancer [PDF]

, 2008
Yau, TCC
core  

Epidemiology and antifungal susceptibilities of rare yeast infections in a tertiary care center. [PDF]

BMC Microbiol
Yavuz B, Turhan Ö, Özyurt ÖK, Çetinkaya Ö, Ayaz ÇM, Özhak B, Mamıkoğlu L.   +6 more
europepmc   +1 more source

Infectious endocarditis caused by Candida glabrata: evidence of in vivo development of echinocandin resistance.

, 2019
Caroline Agnelli, Jesús Guinea, Maricela Valerio, Pilar Escribano, Emilio Bouza, Patricia Muñóz   +5 more
openalex   +1 more source

Invasive Candidiasis in Contexts of Armed Conflict, High Violence, and Forced Displacement in Latin America and the Caribbean (2005-2025). [PDF]

J Fungi (Basel)
Rivas-Pinedo P, Motta JC, Gutierrez JMO.
europepmc   +1 more source

Recent innovations and challenges in the treatment of fungal infections. [PDF]

Front Cell Infect Microbiol
Liu D, Zhou R, Gao X.
europepmc   +1 more source

Rezafungin: an opportunity to personalize the treatment of patients with candidemia. [PDF]

Crit Care
Honore PM, Cornely OA, Soriano A.
europepmc   +1 more source